METAIAM wins first place at NYC cross-border startup competition

METAIAM took first place at the 2026 NYC Cross-Border US Startup Competition on Oct. 10 at NYU’s Vanderbilt Hall in New York. Nine AI, life sciences and healthcare ventures were recognized at the event, which brought together founders, investors and industry professionals.

Why it matters: - The competition spotlighted startups building products for enterprise security, sales technology and healthcare. - METAIAM’s human-presence verification targets a growing risk: autonomous AI systems and deepfakes used in high-stakes approvals. - The event also connected founders with investors, industry professionals and potential partners.

What happened: - METAIAM won first place at the 2026 NYC Cross-Border US Startup Competition, held Oct. 10 at New York University’s Vanderbilt Hall. - Orbitour AI placed second. - Thread Bioscience and medara tied for third. - Each of the four top teams also received an Excellence Award. - David Tang represented METAIAM. - Zihao Zhang represented Orbitour AI. - Craig Serio represented Thread Bioscience. - Kendra Batchelder, Ph.D., represented medara. - The event was organized by the New York University Chinese Students and Scholars Association and the Chinese Legal and Social Advancement Association.

The details: - The program included startup pitches, keynote addresses, a panel discussion and an awards ceremony. - METAIAM develops technology to verify that a real person is behind high-risk enterprise authorizations. - Orbitour AI combines an AI sales assistant with interactive, photorealistic 3D representations of venues. - Thread Bioscience is developing CultureStat, a point-of-care bacterial testing platform for assessing urinary tract infections. - medara is building AI tools for breast cancer screening and risk assessment. - Five additional ventures received Outstanding Project recognition, bringing the total number of recognized projects to nine. - Aident AI connects AI agents with tools, accounts and data to support business workflows. - Qnity is developing quantum-electrochemical sensors for molecular screening. - SATORI combines AI and synthetic biology to discover and produce bioingredients. - Haystack Medical is building a microneedle platform for inner-ear fluid sampling and targeted drug delivery. - Miora Health combines at-home microbiome testing with AI to assess the risk of pregnancy complications during the first trimester. - CLSA President Yi Lee delivered opening remarks. - Keynote speakers included Andreas Deutschmann, managing partner at InFound Equity and a former managing director at JPMorgan Chase, and Max Ren, a senior global media executive and founder and CEO of Starr Holdings. - Ryan Zhang moderated the panel “From Innovation to Market.” - Panelists included Fannie Wang of UpHonest Capital, Venkat Nelabhotla of Vyome Holdings Inc., Srushti Katore of CARA Systems Inc. and Chuck English of English Ventures. - The agenda also included an ATTENCITY Go-to-Market session and guest commentary. - Award presenters included Dan Zhang, vice president of Q Bay Center, and Michael Zhao, co-founder of Q Bay (Boston).

Between the lines: - The lineup suggests growing investor interest in cross-border ventures spanning AI, biotech and healthcare. - The mix of pitch competition, panel programming and networking points to a broader goal than awards alone. - The event’s structure gave startups a forum to present both product ideas and market-readiness signals.

What's next: - NCUSC says it will continue to bring together entrepreneurs, investors and technology professionals to showcase emerging ventures and foster cross-border collaboration. - The competition also aims to connect founders with industry resources and potential partners. - NYU CSSA and CLSA both describe ongoing programming focused on cultural, professional and networking support.

The bottom line: - METAIAM emerged as the top winner in a field that highlighted early-stage AI and healthcare companies with commercial and technical ambitions.